Pregn-3-eno[4,3-b][1,4]oxazepine(8CI,9CI)(25002-21-5)
- Name: Pregn-3-eno[4,3-b][1,4]oxazepine(8CI,9CI)
- Synonyms:6H-Cyclopenta[7,8]phenanthro[1,2-b][1,4]oxazepine,pregn-3-eno[4,3-b][1,4]oxazepine deriv.; 6H-Cyclopenta[7,8]phenanthro[1,2-b][1,4]oxazepine,10-ethyl-7,7a,7b,8,9,9a,10,11,12,12a,12b,13,14,14a-tetradecahydro-7a,9a-dimethyl-,[7aR-(7aa,7bb,9aa,10a,12ab,12ba)]-; [7aR-(7aa,7bb,9aa,10a,12ab,12ba)]-10-Ethyl-7,7a,7b,8,9,9a,10,11,12,12a,12b,13,14,14a-tetradecahydro-7a,9a-dimethyl-6H-cyclopenta[7,8]phenanthro[1,2-b][1,4]oxazepine
- Molecular Formula:C24H35 N O
- Molecular Weight:
- CAS Registry Number:25002-21-5
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 133147-10-1/methyl 5-[(2-ethoxyethoxy)carbamoyl]-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate
- 75132-75-1/188673-65-6
- 5432-37-1/2-(2,5-dioxoimidazolidin-4-yl)-N,N-diethylethanesulfonamide
- 91599-28-9/Cyclopenta[c]pyran-4-carboxylic acid,1-(â-D-glucopyranosyloxy)-1,4a,5,6,7,- 7a-hexahydro-7-hydroxy-5-[[(2E)-3-(4- hydroxy-3-methoxyphenyl)-1-oxo-2-propenyl]- oxy]-7-methyl-,(1S,4aS,5R,7S,7aS)-
- 37989-06-3/1-Isoquinolinamine, 3-(2-furanyl)-
- 27321-50-2/methyl (4Z)-4-(3,3-dimethyltriazanylidene)-4H-pyrazole-3-carboxylate
- 79010-26-7/1-(3-acetyl-4-{2-hydroxy-3-[(1-methylethyl)amino]propoxy}phenyl)propan-1-one
- 53511-34-5/1-hydroxy-1-oxo-2-[(6Z)-6-(6-oxocyclohexa-2,4-dien-1-ylidene)-4-phenyl-1,6-dihydropyrimidin-2-yl]diazanium
- 603-23-6/3-PHENYL-2,4(1H,3H)-QUINAZOLINEDIONE
- 139886-03-6/(E)-N-methoxy-1-(1,2,5,6-tetrahydropyridin-3-yl)methanimine hydrochloride (1:1)
- 7582-21-0/3-[(2-methylacryloyl)oxy]propane-1-sulfonic acid
- 672-67-3/2H-PYRAN-2-ONE-6-CARBOXYLIC ACID
- 137604-97-8/Prochaetoglobosin IV
- 79702-43-5/Ethanaminium,N-(carboxymethyl)-N,Ndimethyl- 2-[(2-methyl-1-oxo-2-propenyl)- oxy]-,inner salt,homopolymer
- 96470-90-5/Amides, from ammonia-ethanolamine reaction by-products and caustic-oxidized castor-oil fatty acid distn. residues
- 14508-18-0/Cholan-24-oic acid,3-(acetylhydrazono)- (9CI)
- 68686-79-3/1-methyl-1-nitrosoguanidine
- 57232-93-6/2-de-L-Histidine-6-D-leucine luteinizing hormone releasing factor
- 26669-42-1/1,3,5-Triazine-2,4-diamine,6-azido-N2-cyclopropyl-N4-ethyl-
- 25002-21-5/Pregn-3-eno[4,3-b][1,4]oxazepine(8CI,9CI)
- 119189-41-2/Phenol,4,4'-(1,4-butanediyl)bis[2-methoxy-
- 68585-48-8/Sulfuric acid, nickel(2+) salt (1:1), reaction products with nickeland nickel oxide (NiO)
- 51368-79-7/phenyl (2S,4S,4aS,8aR)-2-ethyl-1,2-dimethyldecahydroquinoline-4-carboxylate hydrochloride
- 141079-11-0/2-{5-[(4-chloro-3-methylphenoxy)methyl]-4-(4-methylphenyl)-4H-1,2,4-triazol-3-yl}pyrimidine
- 603-32-7/TRIPHENYLARSINE
- 32794-45-9/2-(didodecylamino)-N-[4-[4-[[2-(didodecylamino)acetyl]amino]phenyl]sulfonylphenyl]acetamide
- 102848-64-6/Olean-12-en-28-oicacid, 3-(a-L-arabinopyranosyloxy)-29-hydroxy-,b-D-glucopyranosyl ester, (3b,20a)-
- 68607-20-5/Quaternary ammonium compounds, benzyl-C16-18-alkyldimethyl, chlorides
- 24269-85-0/cyclohexyl 4-[2-(propan-2-ylamino)ethyl]piperazine-1-carboxylate hydrochloride (1:1)
- 73038-31-0/Chromate(5-),bis[5-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2-hydroxy-5-nitrophenyl)azo]-2,7-naphthalenedisulfonato(4-)]-,tetrapotassium sodium